-
May 10, 2023 MindMed: Can the Former Darlings of the Psychedelic Biotech Sector Avoid Collapse?After MindMed's up-listing, the company has been facing a lot of instability and turbulence in...
-
October 6, 2022 Math Over Myth: Weekly Psychedelic Stocks News RoundupGet the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin...
-
August 19, 2022 Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine CollapsesThe psychedelic renaissance hits a rough patch as major companies look to tighten their belts...
-
June 16, 2022 The Four Psychedelics ETFs Capturing Investor AttentionDespite an overarching shared thesis, the four psychedelics ETFs differ in philosophy, strategy, execution, and...
-
May 17, 2022 Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisOur resident psychedelic investor explains a handful of important metrics to study when analyzing and...
-
April 22, 2022 Understanding 3 Risks of Investing in Psychedelic StocksNo one is responsible for your financial future, other than yourself, so be responsible with...
-
March 25, 2022 Interested in Psychedelic Stocks? This Is the BEST Resource for YouIntroducing the Benzinga Psychedelics Capital Conference on April 19 in Miami Beach,
-
March 18, 2022 Is Small Pharma a Good Psychedelic Stock Investment?Our resident Psychedelic Investor James Hallifax looks at the pros and cons of this Canadian-based...
-
March 7, 2022 Is Wall Street the Next Stop for Psychedelics? Investing in the Psychedelic Medicine SectorElemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future...
-
February 21, 2022 How Long Until Psychedelic Stocks Payoff?Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing...
